Developing a Comprehensive Selection Framework for Centralized Pharmaceutical Procurement Based on a Hybrid Multi-Criteria Decision-Making Approach

preprint OA: closed
Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-14

This study developed and validated a hybrid multi-criteria decision-making framework integrating DNMA, CRITIC, and MAHP methods to systematically screen and select drugs for centralized procurement.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text

This preprint studied how to build a decision-making framework to support China’s National Centralized Drug Procurement by balancing procurement mandates with clinical appropriateness. Using a hybrid multi-criteria decision-making approach that integrates DNMA with CRITIC and MAHP, the authors constructed a factor system via literature review and Delphi surveys, yielding 8 dimensions and 15 critical criteria, and tested it with a real-world case study showing it can capture nonlinear interdependencies among decision factors to improve rigor and transparency. The paper presents results at the framework and case-study level and does not provide peer-reviewed validation beyond this preprint. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract BackgroundChina’s National Centralized Drug Procurement (NCDP) policy faces challenges in reconciling procurement mandates with clinical appropriateness. A robust decision-making framework for drug selection is critical to comprehensively evaluate centralized procurement processes. Existing studies lack systematic analysis of decision-influencing factors, while overreliance on single normalization methods often introduces outcome uncertainties.MethodsTo address these gaps, this study developed a hybrid multi-criteria decision-making (MCDM) framework. It integrates the Double Normalization-based Multiple Aggregation (DNMA) method with Criteria Importance Through Intercriteria Correlation (CRITIC) and Multiplicative Analytic Hierarchy Process (MAHP) to establish a screening and selection system. The factor system was constructed through literature review and Delphi surveys.Results(a) A decision factor system for evaluating centralized procurement drugs was established, comprising 8 dimensions and 15 critical criteria. (b) A real-world case study confirmed that the framework effectively captures nonlinear interdependencies among decision factors, enhancing the scientific rigor and transparency of outcomes.ConclusionsThis study advances scientifically grounded, systematic drug selection for centralized procurement. By proposing a feasible MCDM framework, it facilitates effective NCDP implementation and precise policy allocation, strengthening the alignment between procurement efficiency and clinical appropriateness.
Full text 13,562 characters · extracted from preprint-html · click to expand
Developing a Comprehensive Selection Framework for Centralized Pharmaceutical Procurement Based on a Hybrid Multi-Criteria Decision-Making Approach | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Developing a Comprehensive Selection Framework for Centralized Pharmaceutical Procurement Based on a Hybrid Multi-Criteria Decision-Making Approach Jie Zhao, Youhong Hu, Yun Lu, Shuzhang Du, Yan Liang This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6849760/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 5 You are reading this latest preprint version Abstract Background China’s National Centralized Drug Procurement (NCDP) policy faces challenges in reconciling procurement mandates with clinical appropriateness. A robust decision-making framework for drug selection is critical to comprehensively evaluate centralized procurement processes. Existing studies lack systematic analysis of decision-influencing factors, while overreliance on single normalization methods often introduces outcome uncertainties. Methods To address these gaps, this study developed a hybrid multi-criteria decision-making (MCDM) framework. It integrates the Double Normalization-based Multiple Aggregation (DNMA) method with Criteria Importance Through Intercriteria Correlation (CRITIC) and Multiplicative Analytic Hierarchy Process (MAHP) to establish a screening and selection system. The factor system was constructed through literature review and Delphi surveys. Results (a) A decision factor system for evaluating centralized procurement drugs was established, comprising 8 dimensions and 15 critical criteria. (b) A real-world case study confirmed that the framework effectively captures nonlinear interdependencies among decision factors, enhancing the scientific rigor and transparency of outcomes. Conclusions This study advances scientifically grounded, systematic drug selection for centralized procurement. By proposing a feasible MCDM framework, it facilitates effective NCDP implementation and precise policy allocation, strengthening the alignment between procurement efficiency and clinical appropriateness. Centralized Procurement Multi-Criteria Decision-Making Probabilistic Linguistic Term Double Normalization-based Multiple Aggregation Nonlinear correlation Full Text Additional Declarations No competing interests reported. Supplementary Files SupplementaryMaterial.docx Cite Share Download PDF Status: Under Review Version 1 posted Reviewers invited by journal 15 Jul, 2025 Editor assigned by journal 09 Jul, 2025 Editor invited by journal 17 Jun, 2025 Submission checks completed at journal 16 Jun, 2025 First submitted to journal 16 Jun, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6849760","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":486012026,"identity":"4a572547-3f61-40db-9383-6889768d954f","order_by":0,"name":"Jie Zhao","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA4ElEQVRIiWNgGAWjYDACCRA2YODhZ28++CChooZ4LTKSPceSDR6cOUakFiCwMbiRYyb5sIWZsA752c0PH1gU2PBI9pwxq0hsYGPgb+9OwKuFcc4xYwMJgzSgX9rKbiTukGGQOHN2A14tzBIJZhISBoeBthzediPxDBuDgUQufi1sEunfgFr+8xjcSDArSGxjJqyFRyIHZMsBoJYUMwaitEhI5BQD/ZLMAwpkiYQzx3gI+kV+RvrGxxJ/7OxBUfnxR0WNHH97L34tIMAsgexSgspBgPEDUcpGwSgYBaNgxAIAJgZFLakGiowAAAAASUVORK5CYII=","orcid":"","institution":"The First Affiliated Hospital of Zhengzhou University","correspondingAuthor":true,"prefix":"","firstName":"Jie","middleName":"","lastName":"Zhao","suffix":""},{"id":486012027,"identity":"0b08d1c0-e024-4da5-9604-d9348d2e6da4","order_by":1,"name":"Youhong Hu","email":"","orcid":"","institution":"The First Affiliated Hospital of Zhengzhou University","correspondingAuthor":false,"prefix":"","firstName":"Youhong","middleName":"","lastName":"Hu","suffix":""},{"id":486012028,"identity":"b7269e7f-7dc6-41eb-8f2d-e53ed30eff32","order_by":2,"name":"Yun Lu","email":"","orcid":"","institution":"China Pharmaceutical University","correspondingAuthor":false,"prefix":"","firstName":"Yun","middleName":"","lastName":"Lu","suffix":""},{"id":486012029,"identity":"04e39743-2817-48c0-8aa8-7fd0d2bb70b9","order_by":3,"name":"Shuzhang Du","email":"","orcid":"","institution":"The First Affiliated Hospital of Zhengzhou University","correspondingAuthor":false,"prefix":"","firstName":"Shuzhang","middleName":"","lastName":"Du","suffix":""},{"id":486012030,"identity":"ccbee378-566a-48a9-9a8d-6dd6805284a4","order_by":4,"name":"Yan Liang","email":"","orcid":"","institution":"The First Affiliated Hospital of Zhengzhou University","correspondingAuthor":false,"prefix":"","firstName":"Yan","middleName":"","lastName":"Liang","suffix":""}],"badges":[],"createdAt":"2025-06-09 01:38:19","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-6849760/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-6849760/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":87467486,"identity":"23d65193-4d2e-445e-8581-72f0260c918b","added_by":"auto","created_at":"2025-07-24 08:10:36","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":692095,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6849760/v1_covered_844706ea-1ec1-4230-9a6c-e824c3ef0dda.pdf"},{"id":86964466,"identity":"aff18d32-3b7a-4b5f-9518-b32459b0a9fb","added_by":"auto","created_at":"2025-07-17 17:05:03","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":39242,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryMaterial.docx","url":"https://assets-eu.researchsquare.com/files/rs-6849760/v1/2d8b3cc78cf37382708642c7.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Developing a Comprehensive Selection Framework for Centralized Pharmaceutical Procurement Based on a Hybrid Multi-Criteria Decision-Making Approach","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"bmc-health-services-research","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"bhsr","sideBox":"Learn more about [BMC Health Services Research](http://bmchealthservres.biomedcentral.com/)","snPcode":"","submissionUrl":"https://www.editorialmanager.com/BHSR/default.aspx","title":"BMC Health Services Research","twitterHandle":"BMC_series","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"em","reportingPortfolio":"BMC Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Centralized Procurement, Multi-Criteria Decision-Making, Probabilistic Linguistic Term, Double Normalization-based Multiple Aggregation, Nonlinear correlation","lastPublishedDoi":"10.21203/rs.3.rs-6849760/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6849760/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cb\u003eBackground\u003c/b\u003e\u003c/p\u003e\u003cp\u003eChina\u0026rsquo;s National Centralized Drug Procurement (NCDP) policy faces challenges in reconciling procurement mandates with clinical appropriateness. A robust decision-making framework for drug selection is critical to comprehensively evaluate centralized procurement processes. Existing studies lack systematic analysis of decision-influencing factors, while overreliance on single normalization methods often introduces outcome uncertainties.\u003c/p\u003e\u003cp\u003e\u003cb\u003eMethods\u003c/b\u003e\u003c/p\u003e\u003cp\u003eTo address these gaps, this study developed a hybrid multi-criteria decision-making (MCDM) framework. It integrates the Double Normalization-based Multiple Aggregation (DNMA) method with Criteria Importance Through Intercriteria Correlation (CRITIC) and Multiplicative Analytic Hierarchy Process (MAHP) to establish a screening and selection system. The factor system was constructed through literature review and Delphi surveys.\u003c/p\u003e\u003cp\u003e\u003cb\u003eResults\u003c/b\u003e\u003c/p\u003e\u003cp\u003e(a) A decision factor system for evaluating centralized procurement drugs was established, comprising 8 dimensions and 15 critical criteria. (b) A real-world case study confirmed that the framework effectively captures nonlinear interdependencies among decision factors, enhancing the scientific rigor and transparency of outcomes.\u003c/p\u003e\u003cp\u003e\u003cb\u003eConclusions\u003c/b\u003e\u003c/p\u003e\u003cp\u003eThis study advances scientifically grounded, systematic drug selection for centralized procurement. By proposing a feasible MCDM framework, it facilitates effective NCDP implementation and precise policy allocation, strengthening the alignment between procurement efficiency and clinical appropriateness.\u003c/p\u003e","manuscriptTitle":"Developing a Comprehensive Selection Framework for Centralized Pharmaceutical Procurement Based on a Hybrid Multi-Criteria Decision-Making Approach","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-07-17 17:04:56","doi":"10.21203/rs.3.rs-6849760/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"reviewersInvited","content":"","date":"2025-07-15T15:14:44+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-07-09T07:12:05+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2025-06-17T10:12:50+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-06-17T03:07:05+00:00","index":"","fulltext":""},{"type":"submitted","content":"BMC Health Services Research","date":"2025-06-17T03:02:10+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"bmc-health-services-research","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"bhsr","sideBox":"Learn more about [BMC Health Services Research](http://bmchealthservres.biomedcentral.com/)","snPcode":"","submissionUrl":"https://www.editorialmanager.com/BHSR/default.aspx","title":"BMC Health Services Research","twitterHandle":"BMC_series","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"em","reportingPortfolio":"BMC Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"bff7de70-737e-42b8-b789-688dca379485","owner":[],"postedDate":"July 17th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[],"tags":[],"updatedAt":"2025-07-17T17:04:58+00:00","versionOfRecord":[],"versionCreatedAt":"2025-07-17 17:04:56","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-6849760","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6849760","identity":"rs-6849760","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00